Primary Open-angle Glaucoma

Showing NaN - NaN of 6

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (PF-04217329 - Lowest Dose, PF-04217329 - Low Dose,

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • PF-04217329 - Lowest Dose
  • +8 more
  • Artesia, California
  • +22 more
Apr 6, 2021

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Ocular Insert)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Fayetteville, Arkansas
  • +9 more
May 18, 2020

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Fayetteville, Arkansas
  • +8 more
Mar 26, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Feb 1, 2019

Primary Open-Angle Glaucoma, Ocular Hypertension Trial in United States (Bimatoprost, Timolol 0.5%, Placebo Eye Drops)

Completed
  • Primary Open-Angle Glaucoma
  • Ocular Hypertension
  • Artesia, California
  • +9 more
Mar 22, 2018

Ocular Hypertension, Primary Open-Angle Glaucoma Trial in Newport Beach (AGN-210961 Formulation 1, AGN-210961 Formulation 2,

Completed
  • Ocular Hypertension
  • Primary Open-Angle Glaucoma
  • AGN-210961 Formulation 1
  • +7 more
  • Newport Beach, California
    (unnamed)
Jul 10, 2014